The treatment of infertility can be an emotional and financial struggle for many couples. Over the years, physicians have tried to evaluate a couple’s fertility treatment success prior to undergoing treatment in the effort to reduce their stress and give them a true sense of the probability of achieving pregnancy.
The ability to test for anti-mullerian hormone (AMH) has been a huge advancement to predict a woman’s response to ovarian stimulation and egg production prior to beginning infertility treatment. AMH is produced by the cells in the ovarian follicle and can be tested at any time during a woman’s cycle. Advantages to using the AMH test are:
- There is very little variation in the hormone level from cycle to cycle.
- Aging or failing ovaries can be diagnosed early. Testing AMH can be useful for young women that want to delay their childbearing as it is prognostic of their ovarian function and can predict early ovarian problems better than other, more commonly used tests.
It is the belief of fertility doctors at Nevada Fertility Center that AMH should not be used alone to guide treatment, but rather be used with other information, like maternal age. It is well known that a woman’s fertility declines as she ages. Some older women falsely believe that their egg quality is good because they are still having regular periods. Testing for AMH every 6 months will give these women an evaluation of their ovarian function and help to predict their response to ovarian stimulation and good egg production.
If you would like to schedule an in-person or Skype consultation with Nevada Fertility Center, please contact us here.